Clinical trials: Untreated Operable Early Breast Cancer
Untreated Operable Early Breast Cancer
Randomized Phase II Study to Assess PD 0332991 in Breast Cancer
This is a Phase II study trying to identify whether short term treatment with PD0332991 yields anti-proliferative response -defined by a low level of Ki67 expression (IHC) at surgery- or induces senescence as determined by SABG…
- Trial name
- POP (NCT02008734)
- Testing
- PD0332991
- Where
- France
- Volunteers
- 132 people
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris